https://www.avient.com/sites/default/files/2020-09/oncap-hc-product-bulletin.pdf
Values reported as “typical” or stated without a range do not state minimum or maximum properties; consult your
sales representative for property ranges and min/max specifications.
https://www.avient.com/sites/default/files/resources/Resilience%2520LS%2520Diffuse%2520Comparison%2520Guide_No%2520CP.pdf
Values reported as “typical” or stated without a range do not
state minimum or maximum properties; consult your sales representative for property ranges and min/max specifications.
https://www.avient.com/sites/default/files/2024-03/Gravi-Tech Product Bulletin_A4.pdf
Values reported as “typical” or stated without a range do not state minimum or maximum properties; consult your sales
representative for property ranges and min/max specifications.
https://www.avient.com/sites/default/files/2024-12/2024 Shooting Sports Selection Guide.pdf
Values reported as “typical” or stated without a range do not state minimum or maximum properties; consult your
sales representative for property ranges and min/max specifications.
https://www.avient.com/sites/default/files/2024-06/ECCOH 5981 for Teck 90 Cables Product Bulletin.pdf
Values reported as “typical” or stated without a range do not state minimum or maximum properties; consult your
sales representative for property ranges and min/max specifications.
https://www.avient.com/sites/default/files/2025-02/ColorMatrix Amosorb 4020L Product Bulletin.pdf
Values reported as “typical” or stated without a range do not state minimum or maximum properties; consult your sales
representative for property ranges and min/max specifications.
https://www.avient.com/sites/default/files/resources/PolyOne%2520IR%2520Presentation%2520Sidoti%2520wNonGAAP%2520Rec.pdf
Page 3
Strategy and Execution Drive Results
90%
$22
$24
PolyOne
Stock Price
50%
$18
$20
$22
S&P 500 (relative performance)
30%
$12
$14
$16
S&P 500 (relative performance)
‐10%
10%
$6
$8
$10
50%
‐30%
$0
$2
$4
$
|
‐50%$0
2006 2007 2008 2009 2010 2011 2012 2013
Page 4
Four Pillar Strategy
The World’s Premier Provider of SpecializedThe World s Premier Provider of Specialized
Polymer Materials, Services & Solutions
Page 5
Spartech – Compelling Strategic Rationale
• Spartech expands PolyOne’s specialty portfolio with adjacent
technologies in attractive end markets
Bolt on acquisition with opportunity for global expansion as only Bolt‐on acquisition with opportunity for global expansion, as only
6% of Spartech’s revenues are outside of North America
• PolyOne has a proven management team with a track record of
transformational success
• Preliminary synergy estimated at $65 million run rate by end of
3year 3
Significant opportunity to expand profitability by leveraging
PolyOne’s four pillar strategy
• Substantial potential share price appreciation for all
shareholders
f f ll / $ Accretive to EPS in first full year post‐acquisition / $0.50 once
synergies realized
Page 6
Mix Shift Highlights Specialty Transformation
Old
PolyOne Transformation
100%
2015
Target
80%
In
co
m
e*
65 – 75%40%
60%
f O
pe
ra
tin
g
34% 43% 45%
65 75%
20%
o
f
2%0%
2005 2008 2010 2012 2015
Specialty OI $5M $46M $87M $114M Target
*Operating Income excludes corporate charges and special items
JV's PP&S Distribution Specialty
Page 7
Proof of Performance
2007 2012 2015
“Where we were” “Where we are” “Where we Where we were Where we are expect to be"
1) Operating Income %
Specialty 3.2% 9.1% 12 – 16%
PP&S 6.1% 9.0% 9 – 12%
Distribution 3.0% 6.4% 6 – 7.5%
2) Specialty Platform
sss% of Operating Income 20% 45% 65 – 75%
3) ROIC* ( ft t ) 7% 11% 15%3) ROIC* (after‐tax) 7% 11% 15%
4) Adjusted EPS Growth** N/A 4 yr CAGR = 55% Double Digit
Expansion
*ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period
**4 yr EPS CAGR calculated using 2012 adjusted EPS vs 2008 adjusted EPS
Page 8
Proof of Performance
Spartech Opportunity
Intermediate
PolyOne Spartech Opportunity
2006 2012 Today Goal
“Where we
were”
“Where we
are”
“Where
Spartech is”*
“Where we
can go”were are Spartech is can go
Specialty
Operating
Margin
1.5% 9.1% 2.2% 8.0% – 10.0%
Margin
Page 9
*Pro Forma results include Spartech corporate allocations for FY12 ended November 3, 2012
PolyOne
14%
Latin
America
3% Distribution
2012 Revenues: $4.2 Billion* 2012 Revenues: $4.2 Billion*
United
States
14% 5%
PP&S
20%Specialty
57%
Building & HealthCare
1.02
1.20
$1.20
$1.40
ha
re
End Markets* EPS Growth
Construction
14%
17%
Industrial
9%
0.27 0 21
0.79
$0.40
$0.60
$0.80
$1.00
Ad
ju
st
ed
E
ar
ni
ng
s P
er
S
Electrical &
0.12
0.21 0.13
$0.00
$0.20
2006 2007 2008 2009 2010 2011 2012
Page 10
* Pro Forma includes FY2012 results for Spartech (11/03/12 YE) and Glasforms
Specialty
U it d
2012 Revenues: $2.4 Billion* Solutions
United
States
59%
9%
Latin
America
Building &
C t ti
HealthCare
o
f S
al
es
12-16%
End Markets* Expanding Profits
Construction
Electrical &
Industrial
15%
1.5%
3.2% 4.3%
5.3%
8.4% 9.1%
O
pe
ra
tin
g
In
co
m
e
Page 11
2006 2007 2008 2009 2010 2011 2012 2015
O
Target* Pro Forma includes FY2012 results for Spartech (11/03/12 YE) and Glasforms
Designed Structures and Solutions
United States
2012 Revenues: $0.85 Billion* Solutions
84%
Latin America
4% Building & Construction
Sign & Advertising
3%
Recreation & Leisure
Pool & Spa
1%
Distribution &
Thermoform
2% Operating Income % of Sales
2012 Revenue by Industry Segment* Expanding Profits**
Electrical & Electronics
23%Industrial
3%
2.2%
8 ‐ 10%
1%
HealthCare
2012 2015
Target
Page 12
*Pro Forma includes FY2012 results for Spartech (11/03/12 YE)
**Pro Forma results include Spartech corporate allocations for FY12
Positioned for Earnings Growth
2015 Target
Rev: $5B
Adj.
https://www.avient.com/sites/default/files/2023-10/SEM Automotive Aftermarket Rendering Application Bulletin.pdf
Values reported as “typical” or stated without a range do not state minimum or maximum properties; consult your
sales representative for property ranges and min/max specifications.
https://www.avient.com/sites/default/files/2023-01/Mevopur Healthcare Functional Additives_Laser Welding Additives for Medical Devices Application Bulletin.pdf
Values reported as “typical” or stated without a range do not state minimum or maximum properties; consult your sales
representative for property ranges and min/max specifications.
https://www.avient.com/sites/default/files/2022-03/Trilliant HC Electrically Conductive Formulations for Pipette Tips Application Bulletin.pdf
Values reported as “typical” or stated without a range do not state minimum or maximum properties; consult your
sales representative for property ranges and min/max specifications.